Growth Hormone Secretagogue Blend
CJC-1295 / Ipamorelin is a formulation commonly used in growth hormone pathway research. By combining a growth hormone-releasing hormone analog with a selective ghrelin receptor agonist, this pairing works through complementary signaling mechanisms involved in natural growth hormone release.
Researchers frequently use this combination in studies focused on recovery, sleep quality, and body composition signaling. The coordinated interaction between CJC-1295 and Ipamorelin enables investigation of balanced growth hormone pulse activity and downstream metabolic pathways.
Key Areas of Research Interest
Supports natural growth hormone signaling linked to recovery and physical performance
Helps the body recover faster after intense training or physical stress
Promotes deeper sleep and supports overnight repair processes
Supports lean muscle maintenance while helping regulate fat metabolism
Helps maintain balanced and consistent growth hormone release patterns
Mechanism of Action
CJC-1295 functions as a growth hormone-releasing hormone analog that interacts with receptors that stimulate growth hormone signaling pathways. Ipamorelin acts as a selective ghrelin receptor agonist that promotes growth hormone pulse activity through a separate but complementary mechanism.
Together, these compounds influence two distinct regulatory pathways associated with endogenous growth hormone release. This dual-pathway activity allows researchers to examine coordinated signaling related to recovery processes, metabolic function, and regenerative biological pathways.
Product Specifications
Compound: CJC-1295 / Ipamorelin Blend
Form: Lyophilized Powder
Chemical Name: CJC-1295 (Modified Growth Hormone Releasing Hormone Analog)
Ipamorelin (Growth Hormone Secretagogue)
Molecular Weight: CJC-1295: ~3647.2 g/mol Ipamorelin: ~711.9 g/mol
Appearance: White to off-white sterile lyophilized powder
Research Application: Growth hormone secretagogue research, metabolic pathway studies, recovery signaling analysis, and compound interaction research.
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose, treat, cure, or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. Only qualified professionals should handle this compound in appropriate research or laboratory settings.
CJC-1295
Ipamorelin
Long-Acting Dual-Receptor Analog
G2-T (Tirz) represents a significant advancement in metabolic research, positioned as a dual-agonist compound engineered to engage two primary incretin pathways—GLP-1 and GIP receptors. This dual-pathway design builds upon earlier single-agonist frameworks, offering enhanced regulatory control within energy intake, glucose-related signaling, and adipose metabolism research models.
Through coordinated receptor engagement, G2-T is structured to support more efficient metabolic signaling than first-generation incretin compounds, making it a key developmental step in research optimization.
Key Areas of Research Interest
Dual activation of GLP-1 and GIP receptor pathways
Enhanced regulation of energy intake–associated signaling
Improved glucose utilization and insulin-related pathway efficiency
Support for metabolic balance during adaptive plateaus
Demonstrated advancement over single-agonist models in comparative studies
Mechanism of Action
G2-T functions as a dual incretin receptor agonist, simultaneously activating GLP 1 and GIP signaling pathways. These pathways are central to metabolic regulation research and influence glucose-dependent signaling, energy intake modulation, and lipid storage dynamics.
By integrating both receptor actions into a single molecular structure, G2-T demonstrates greater signaling efficiency than GLP 1–only compounds such as G1-S. Comparative research has shown improved outcomes across multiple metabolic markers, including adipose-related measurements and glucose-associated endpoints, highlighting its role as an intermediary advancement between single- and triple-agonist development.
Product Specifications
Compound Type: Dual-agonist compound
Classification: GLP-1 / GIP receptor agonist
Administration Route: Subcutaneous (weekly protocols observed in studies)
Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight: ~4,813.03 g/mol
Estimated Half-Life: ~5 days
Development Status: Advanced clinical research
Research Focus: Metabolic signaling, glucose regulation pathways, adipose modulation
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose, treat, cure, or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. Only qualified professionals should handle this compound in appropriate research or laboratory settings.
G3-R
Regenerative Copper Complex
GHK-Cu is a well-established copper-binding compound widely studied in regenerative and cellular signaling research. Naturally occurring in the human body, this copper complex has been extensively studied for its role in supporting tissue repair signaling, skin-associated structural pathways, and overall cellular maintenance.
Within research environments, GHK-Cu is recognized for its ability to interact with gene expression pathways tied to collagen production, antioxidant activity, and structural protein support. Its multifunctional profile has made it a core compound in studies exploring dermal resilience, recovery signaling, and long-term tissue optimization.
By supporting communication between repair-related cellular pathways and structural protein systems, GHK-Cu remains a foundational compound in next-phase research focused on skin quality, follicular support, and connective tissue maintenance.
Key Areas of Research Interest
Supports smoother, firmer skin-related research pathways
Helps promote collagen and elastin activity signals
Encourages healthy hair and scalp research environments
Supports tissue recovery and repair signaling
Helps maintain a balanced inflammation response in studies
Boosts antioxidant and cellular protection pathways
Plays a role in overall skin quality and structural support research
Mechanism of Action
GHK-Cu functions as a copper-binding signaling compound that delivers bioavailable copper to targeted cellular pathways. Copper plays a critical role in multiple enzymatic and structural processes, including collagen formation, antioxidant defense, and tissue repair signaling.
When bound to copper, GHK becomes highly active in cellular communication pathways involved in regeneration and structural maintenance. Research indicates that this complex can influence gene expression related to collagen production, extracellular matrix remodeling, and angiogenesis-associated signaling.
GHK-Cu has also been shown to support balanced inflammatory signaling and oxidative-stress defense pathways, both essential for maintaining tissue integrity and long-term cellular resilience. These combined effects position the compound as central in advanced dermal, follicular, and connective-tissue research models.
Product Specifications
Compound Type: Copper-binding complex
Classification: Regenerative signaling compound
Primary Structure: Glycyl-L-histidyl-L-lysine copper complex
Molecular Formula: C₁₄H₂₄N₆O₄Cu
Molecular Weight: ~403.93 g/mol
Administration Route: Subcutaneous or topical application observed in research settings
Stability Profile: High-stability copper complex
Development Status: Advanced research phase
Research Focus: Skin remodeling pathways, collagen support signaling, follicular research, antioxidant activity, and tissue recovery models
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose, treat, cure, or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. Only qualified professionals should handle this compound in appropriate research or laboratory settings.
KPV
GHRH Analog • Visceral Adipose Research
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog commonly studied for its role in growth hormone signaling, metabolic activity, and body composition support.
Unlike broader growth hormone secretagogues, Tesamorelin stands out for its strong association with visceral adipose tissue pathways, making it a compound of particular interest in research focused on stubborn fat storage around internal organs, metabolic efficiency, and overall body composition changes.
By stimulating natural growth hormone release through targeted pituitary signaling, Tesamorelin helps drive downstream pathways linked to lipid metabolism, recovery, tissue maintenance, and energy utilization.
Key Areas of Research Interest
Frequently studied for its role in reducing visceral adipose tissue (fat stored around internal organs) while improving overall body composition
Stimulates natural growth hormone release through targeted growth hormone-releasing hormone (GHRH) signaling
Supports metabolic function and lipid metabolism pathways to utilize energy and support body composition
Helps preserve lean muscle tissue
Investigated for recovery support, cellular repair processes, and downstream growth hormone activity
Mechanism of Action
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that interacts with pituitary receptors to trigger natural growth hormone release.
Once activated, this signaling helps stimulate pulsatile growth hormone secretion, which can influence downstream pathways tied to fat metabolism, tissue repair, recovery, and overall metabolic function.
What makes Tesamorelin unique is its stronger association with visceral fat pathways compared to more general growth hormone support compounds, making it especially relevant in body composition-focused research
Product Specifications
Compound Type: Synthetic Hormone Analog
Classification: Growth Hormone Releasing Hormone (GHRH) Analog
Primary Structure: 44 Amino Acid Synthetic compound
Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
Molecular Weight: ~5135.9 g/mol
Appearance: White to off-white sterile lyophilized powder
Form: Lyophilized Powder
Administration Route: Subcutaneous
Stability Profile: Lyophilized compound; stable under recommended cold storage conditions prior to reconstitution. Reconstituted stability depends on storage conditions and handling.
Development Status: FDA-approved active pharmaceutical ingredient originally developed for visceral adipose tissue reduction research and metabolic applications
Research Application: Growth hormone signaling, metabolic pathway analysis, visceral fat studies, lipid metabolism pathways, recovery and body composition research
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose, treat, cure, or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. Only qualified professionals should handle this compound in appropriate research or laboratory settings.
G2-T
Triple-Receptor Agonist
G3-R represents the most advanced evolution in metabolic research. Engineered as a triple-agonist compound, it engages three critical regulatory pathways—GLP-1, GIP, and glucagon receptors—in energy balance and substrate utilization. This multi-pathway activation profile distinguishes G3-R as a next-generation compound in body-composition and metabolic optimization research.
Unlike single- or dual-agonist compounds, G3-R is structured to influence both intake signaling and energy expenditure mechanisms, positioning it as a peak-performance option in advanced compound development.
Key Areas of Research Interest
Simultaneous activation of GLP-1, GIP, and glucagon receptor pathways
Upregulation of metabolic rate–associated signaling
Enhanced lipid oxidation pathways with preserved structural tissue signaling
High-precision multi-hormonal pathway engagement
Demonstrated efficacy in overcoming metabolic adaptation observed in prior agonist models
Mechanism of Action
G3-R operates through a triple-agonist signaling framework. Activation of GLP-1 and GIP receptor pathways supports regulated energy intake signaling and glucose-related pathway efficiency. Its additional engagement of glucagon receptors differentiates the compound by promoting increased energy-expenditure signaling and enhanced lipid-mobilization pathways.
This integrated mechanism shifts focus beyond isolated appetite-related pathways toward system-level metabolic modulation. Comparative research data indicate G3-R shows greater overall reductions in adipose-associated markers than dual-agonist compounds such as G1-S and G2-T, particularly in models assessing central and visceral fat signaling.
Product Specifications
Compound Type: Triple-agonist compound
Classification: GLP-1 / GIP / Glucagon receptor agonist
Administration Route: Subcutaneous (weekly protocol observed in studies)
Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
Molecular Weight: 4,731.33 g/mol
Estimated Half-Life: 5–7 days
Development Status: Late-stage clinical research
Research Focus: Metabolic signaling, energy balance modulation, adipose tissue regulation
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose, treat, cure, or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. Only qualified professionals should handle this compound in appropriate research or laboratory settings.
GHK-Cu
Immune-Modulating
Lysine-Proline-Valine (KPV) is a naturally occurring compound derived from the alpha-melanocyte-stimulating hormone (α-MSH) sequence and is widely studied for its role in inflammatory regulation and gut-associated signaling pathways.
In research settings, KPV has drawn attention for supporting balanced inflammatory responses and promoting cellular environments associated with tissue resilience and barrier integrity. Because of its targeted signaling properties, KPV has become a focus in research exploring immune modulation, gastrointestinal health models, and skin-related recovery pathways.
By interacting with regulatory pathways tied to cytokine signaling and inflammatory response control, KPV remains a valuable compound in next-generation research exploring immune balance, epithelial barrier support, and tissue-recovery environments.
Key Areas of Research Interest
Helps support a balanced inflammatory response within the body
Assists in supporting overall tissue recovery and cellular repair environments
Helps the body manage and bring down excessive inflammatory responses
Supports gut health and intestinal barrier function
Promotes a healthier environment for skin recovery and irritation support
Mechanism of Action
KPV functions as a short signaling compound derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). Some research has shown KPV to influence inflammatory signaling pathways, particularly those associated with cytokine activity and immune response regulation.
Research suggests KPV may help modulate pathways tied to NF-κB signaling and other inflammatory mediators involved in immune-system communication. Through these mechanisms, researchers have studied the compound for its ability to support balanced inflammatory environments in gastrointestinal, dermal, and epithelial tissue models.
Because of its targeted signaling properties and relatively small structure, KPV has become an increasingly studied compound in research involving gut-barrier function, immune balance, microbial ecosystem signaling, and tissue-recovery pathways
Product Specifications
Compound Type: Anti-inflammatory signaling compound
Classification: Immune-regulatory compound
Primary Structure: Lysine-Proline-Valine
Molecular Formula: C₁₆H₂₈N₄O₄
Molecular Weight: ~340.42 g/mol
Administration Route: Subcutaneous, topical, or oral; observed in research models
Stability Profile: Stable short-chain structure
Development Status: Active research phase
Research Application: Inflammatory signaling regulation, gut-barrier research, immune modulation pathways, microbial balance models, and tissue-recovery studies
Quality Commitment
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
Research Use Disclaimer
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose, treat, cure, or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. Only qualified professionals should handle this compound in appropriate research or laboratory settings.
Tesamorelin